ASTRAZENECA- AstraZeneca AB - Multi-national Industrial

Organisation description

General description:

General Description: AstraZeneca AB is one of the world's leading pharmaceutical companies. Amongst its products are medicines designed to fight disease in important areas of healthcare: for example Arimidex for cancer, Crestor for cardiovascular disease, Nexium for gastrointestinal disease, Seroquel for schizophrenia and Symbicort for asthma. Sales in 2006 totalled $26.5 billion, with an operating profit of $8.2 billion. AstraZeneca AB employs over 66,000 people, 58% in Europe. Process Research and Development is carried out at four sites in Sweden and in the UK.

Expertise

process development to industrial timescales,
industrial application of chiral science & technology,
process scale-up and transfer to long-term production,
process aspects of crystallization,
handling of highly active materials.

Facilities

General and specialist (chiral, solid-state) analysis, chromatography including
scale-up, general scale-up from 1ml to 6000 litres, PAT in laboratory and pilot plant

Other European projects the organisation has been involved in:

---

Role in the project

Contributes to WP1, WP6, WP7

Key personnel involved in INTENANT
Dr. Martin Hedberg